Bausch & Lomb could go public as early as the end of this year, the Wall Street Journal reported, citing people familiar with the company's thinking.
The eye-care company's Chief Executive Brent Saunders told Reuters last October that he was setting sights on an IPO for the company "in the next couple of years."
Bausch & Lomb and its private equity owner Warburg Pincus declined to comment.
Previously traded on the New York Stock Exchange, the Rochester, New York-based company was acquired for $4.5 billion by Warburg Pincus in late 2007 after falling out of Wall Street's favor because of product recalls, big charges and restatements of earnings.
Bausch & Lomb agreed to buy Ista Pharmaceuticals Inc ISTA.O in March for about $500 million in cash to broaden its portfolio of eye health products.
(Reporting by Ashutosh Pandey in Bangalore; Editing by Supriya Kurane)